06 August 2019
Visiongain has launched a new pharma report Medical Device Contract Manufacturing Market Report: Electronic Manufacturing Services-Medical Diagnostic Devices, Monitoring & Surgical Equipment, and Therapeutic Devices; Materials Processing; and Finished Products.
As growth and competition in the medical device market rise, the opportunity to alleviate cost pressures on medical device OEMs will continue to drive growth within this market. Over the past two decades, medical device outsourcing has become a more prominent strategy for original equipment manufacturers (OEMs). To help OEMs meet business schedules on their core products, contract manufacturing is often used as a mean to expedite certain projects.
The lead analyst of the report commented "The available reduced costs of outsourced manufacturing combined with access to the innovation power of CMOs are major drivers behind the decision to outsource manufacturing processes. CMOs are continually striving to gain competitive advantages by offering superior service, value-added experience and expertise at a lower cost."
Leading companies featured in the report include Benchmark Electronics, Inc., Celestica, Inc., Flextronics Internationa Ltd., Forefront Medical Technology, Greatbatch, Inc., Jabil Circuit, Inc., Nortech Systems, Plexus Corp., Sanmina Corporation, TE Connectivity (Cregenna Medical), Vention Medical, West Pharmaceutical Services, Inc., and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.
25 November 2022
Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.
25 November 2022
The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.
23 November 2022
The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.